Inhibrx Biosciences, Inc. (INBX)
NASDAQ: INBX · Real-Time Price · USD
11.71
+0.54 (4.79%)
At close: May 12, 2025, 4:00 PM
11.71
0.00 (0.00%)
After-hours: May 12, 2025, 4:02 PM EDT
Inhibrx Biosciences Market Cap
Inhibrx Biosciences has a market cap or net worth of $169.51 million as of May 12, 2025.
Market Cap
169.51M
Enterprise Value
24.96M
1-Year Change
n/a
Ranking
Category
Stock Price
$11.71
Market Cap Chart
Since the IPO on May 29, 2024, Inhibrx Biosciences's market cap has decreased from $198.24M to $169.51M, a decrease of -14.49%. That is a compound annual growth rate of -15.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 161.77M | -27.44% |
| Dec 31, 2024 | 222.93M | 12.46% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.08B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |